TABLE 5

Extent of CYP2A13-catalyzed nicotine (CN) metabolism and loss of enzyme activity in the absence and presence of cyanidea


Time

Nicotine Metabolismb

% Activity Remaining
– CN
+ CN
– CN
+ CN
min %
0 0 0 100c 100c
0.5 36 ± 3c,d 14 ± 3e 97 ± 3c 103 ± 5e
1 67 ± 7c 19 ± 2e 89 ± 2c,d 95 ± 4d,e
2 89 ± 4c,d,f 28 ± 5c 78 ± 2c,d,g 96 ± 10c,d
5 95 ± 1d,e,f 53 ± 3d,e,f 66 ± 2d,e,g 88 ± 6d,e,g
10 95 ± 0e,f 78 ± 6c,d,f 53 ± 1d,e,g 77 ± 6c,d,g
16
95 ± 1e,f
94 ± 2d,e,f
47 ± 2d,e,g
76 ± 13d,e,g
  • a CYP2A13 was incubated with 25 μM [5-3H]-(S)-nicotine at 30°C in the presence or absence of 1 mM KCN. At the indicated times, aliquots of the reaction were removed and either analyzed by radioflow HPLC for nicotine metabolites (Fig. 5) or for coumarin 7-hydroxylation in a secondary reaction as described under Materials and Methods. The extent of nicotine metabolism and the percent activity remaining was calculated based on control samples (+ nicotine, – NADPH)

  • b Nicotine metabolism is the sum of total nicotine metabolites compared with total nicotine at time 0

  • c Values are means ± S.D. of four independent experiments

  • d Values are significantly lower than previous time point, P ≤ 0.05

  • e Values are means ± S.D. of three independent experiments

  • f Values are less than those at time 0, P ≤ 0.005

  • g Values are less than those at time 0, P ≤ 0.01